CSL LTD SPON.ADR 2 (F:CSJA) — Market Cap & Net Worth
Market Cap & Net Worth: CSL LTD SPON.ADR 2 (CSJA)
CSL LTD SPON.ADR 2 (F:CSJA) has a market capitalization of $40.06 Billion (€34.26 Billion) as of April 27, 2026. Listed on the F stock exchange, this Germany-based company holds position #659 globally and #141 in its home market, demonstrating a -9.90% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CSL LTD SPON.ADR 2's stock price €18.20 by its total outstanding shares 1941275820 (1.94 Billion). Review how much debt does CSL LTD SPON.ADR 2 carry to assess the company's total debt and financial obligations.
CSL LTD SPON.ADR 2 Market Cap History: 2015 to 2026
CSL LTD SPON.ADR 2's market capitalization history from 2015 to 2026. Data shows change from $72.91 Billion to $42.89 Billion (-3.35% CAGR).
CSL LTD SPON.ADR 2 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CSL LTD SPON.ADR 2's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
7.00x
CSL LTD SPON.ADR 2's market cap is 7.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
35.99x
CSL LTD SPON.ADR 2's market cap is 35.99 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $199.47 Billion | $10.49 Billion | $2.25 Billion | 19.01x | 88.47x |
| 2023 | $195.60 Billion | $13.17 Billion | $2.19 Billion | 14.85x | 89.15x |
| 2024 | $188.37 Billion | $14.69 Billion | $2.64 Billion | 12.82x | 71.30x |
| 2025 | $108.03 Billion | $15.43 Billion | $3.00 Billion | 7.00x | 35.99x |
Competitor Companies of CSJA by Market Capitalization
Companies near CSL LTD SPON.ADR 2 in the global market cap rankings as of April 27, 2026.
Key companies related to CSL LTD SPON.ADR 2 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $109.17 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #336 globally with a market cap of $78.09 Billion USD.
- UCB SA (BR:UCB): Ranked #511 globally with a market cap of $51.74 Billion USD ( €44.26 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #571 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $109.17 Billion | $430.29 |
| #336 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $78.09 Billion | $751.57 |
| #511 | UCB SA | BR:UCB | $51.74 Billion | €239.00 |
| #571 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
CSL LTD SPON.ADR 2 Historical Marketcap From 2015 to 2026
Between 2015 and today, CSL LTD SPON.ADR 2's market cap moved from $72.91 Billion to $ 42.89 Billion, with a yearly change of -3.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €42.89 Billion | -60.29% |
| 2025 | €108.03 Billion | -42.65% |
| 2024 | €188.37 Billion | -3.69% |
| 2023 | €195.60 Billion | -1.94% |
| 2022 | €199.47 Billion | -0.43% |
| 2021 | €200.34 Billion | +5.83% |
| 2020 | €189.30 Billion | -0.50% |
| 2019 | €190.25 Billion | +61.11% |
| 2018 | €118.09 Billion | +24.75% |
| 2017 | €94.66 Billion | +33.48% |
| 2016 | €70.92 Billion | -2.74% |
| 2015 | €72.91 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of CSL LTD SPON.ADR 2 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $40.06 Billion USD |
| MoneyControl | $40.06 Billion USD |
| MarketWatch | $40.06 Billion USD |
| marketcap.company | $40.06 Billion USD |
| Reuters | $40.06 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CSL LTD SPON.ADR 2
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma produ… Read more